Definitions Flashcards

1
Q

Efficacy

A

The maximum therapeutic effect a drug can achieve, weight with least side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Potency

A

The amount of the drug needed to achieve that maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Half-life

A

Time it takes for half of the drug to be removed from the bloodstream. (e.g. Drugs with shorter half life need to be given 3 or 4 times a day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Typical Anti-Psychotics

A

traditional first generation major tranquilizers or neuroleptic drugs used in the treatment of psychiatric disorders. Often produced significant neurological side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Atypical Anti-Psychotics

A

new type of anti-psychotics (second generation) with less neurological side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Typical anti-psychotics mechanism of action

A

Dopamine antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atypical anti-psychotics mechanism of action

A

Dopamine antagonist and serotonin antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antagonist (drug type)

A

Works to block a certain type of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BPSD

A

Behavioural and psychological symptoms of dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Catatonia

A

Abnormality of movement, may involve repetitive overactivity, or catalepsy (rigid trance or seizure with loss of sensation or consciousness) etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Extra pyramidal tracts

A

Start in the brain stem, carries motor fibres to spinal cord. Controls involuntary/autonomic muscle function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Akathisia

A

Muscular discomfort and continuous motor restlessness. Unable to keep still. Can occur whenever but usually in first weeks of treatment. Associated with higher med doses. Anticholinergics effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Psuedo-parkinsonism

A

Tremor, muscle stiffness, shuffling gait, drooling, mask like face, slowed movement. Generally occurs beyond 1 week after starting medication. Due to lowered levels of dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tardive dyskinesia (TD)

A

Spastic facial distortions/movements: mainly tongue, may extend to neck, trunk and extremities. Occurs beyond 6 months of starting treatment usually, may be permanent, occur on discontinuation, or resolve on own.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuroleptic malignant syndrome (NMS)

A

Rigidity, fever, tremor, altered level of consciousness, hypotension, tachycardia, elevated WBC and CK (Creatine Kinase). Mortality 10 – 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anticholinergic side effects

A

Dry, blurred vision, constipation, urinary retention, mydriasis (dilated pupils)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Atypical anti-psychotics, alternative/special uses

A
  • Mood stabilising properties

- BPSD management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Side effects of atypical anti-psychotics

A

Less chance of EPS or NMS than typicals. Associated with metabolic syndromes though: greater risk of weight gain/obesity (and therefore T2DM and CVD), lipid abnormalities, increased prolactin, hypertension. Monitoring of metabolic parameters required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acute dystonia

A

Involuntary muscular contractions or spasms that cause repetitive twisting. Can be painful and frightening. Occurs in neck, throat, and eyes, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CIWA assessment

A

For alcohol addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Passivity delusion

A

Being controlled, thoughts are not one’s own

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clang association

A

Rhyming/similar sounding words

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thought blocking

A

Stops speaking in the middle of a sentence/thought

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Circumstanciality/ circumstantial speech

A

Drifting to a different focus of conversation, but comes back to the point. Irrelevant details make it longer to get to the point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Poverty of ideas/thought

A

No thoughts, feeling of emptiness inside

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Poverty of speech / alogia

A

Restricted speech that does not give any actual information, it is vague and empty, although can be a normal amount of words.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Blunted affect

A

Slow to react - inbetween restricted and flat

28
Q

Flat affect

A

Almost none to no emotional response at all

29
Q

Restricted affect

A

One affect the whole time

30
Q

Euthymic

A

Normal level of mood

31
Q

Dysthymic

A

Depressed mood

32
Q

Labile mood

A

Rapid changing of mood

33
Q

Congruent affect

A

Matches mood

34
Q

Incongruent affect

A

Doesn’t match mood

35
Q

Anhedonia

A

Loss of interest/pleasure

36
Q

Avolition

A

Lack of motivation

37
Q

Affective flattening

A

Symptom of depression, flat affect, showing little to no emotional response externally.

38
Q

Alogia

A

Poverty of speech / thoughts

39
Q

Agnosia

A

Inability to recognise objects (symptom of dementia)

40
Q

Thought insertion

A

Thoughts of another person inserted into the patient’s mind

41
Q

Thought broadcasting

A

Belief that others can hear your thoughts

42
Q

Ideas of reference

A

Belief that occurrences in the world relate to the patient

43
Q

Nihilistic delusion

A

Like dissociation, belief that the patient does not exist, or the patient is dead.

44
Q

Persecutory delusion

A

In danger, under attack, threatened

45
Q

Catatonia

A

Inability to move normally

46
Q

Positive symptoms

A

Adds to patient’s life e.g. hallucinations, delusion

47
Q

Negative symptoms

A

Takes away from patient’s life e.g. anhedonia, avolition

48
Q

Brief psychotic episode

A

Between 1 and 30 days. More than 30 days can be diagnosed schizophrenia or other psychotic disorder

49
Q

Phases of schizophrenia

A

Prodromal, acute, recovery

50
Q

Dialectical behavioural therapy

A

focuses on mindfulness and distress tolerance

51
Q

Motivational interviewing

A

focuses on feelings of ambivalence, best for addictions

52
Q

Electro-convulsive therapy

A

Mostly used for major depression

53
Q

How many older people experience depression?

A

15-20%

54
Q

Stages of dementia

A

Mild, moderate, severe. Moderate being the longest stage, consisting of profound memory loss and disorientation

55
Q

How to activate PSNS (parasympathetic nervous system)?

A

Deep breathing, with a focus on long exhalation

56
Q

Symptoms of alcohol withdrawals

A

Nausea, tremors, agitation

57
Q

Acetylcholine

A

Neurotransmitter that stimulates muscles and memory function. Relates to dementia

58
Q

GABA

A

Neurotransmitter that regulates excitatory neurons and electric activity. Relates to anxiety.

59
Q

Serotonin

A

Neurotransmitter that inhibits behaviour and activity, enhances sleep. Relates to depression.

60
Q

Dopamine

A

Neurotransmitter that regulates decision making, fine muscle movement, emotions and thoughts. Relates to psychosis/schizophrenia (and parkinsons)

61
Q

Epinephrine

A

Neurotransmitter related sympathetic nervous system (paranoia, mania vs. low, dull, depression)

62
Q

Norepinephrine

A

Neurotransmitter that relates to sympathetic nervous system, alertness, focus and attention. (anxiety, paranoia vs. low, dull, depression)

63
Q

Glutamate

A

Neurotransmitter that relates to memory, metabolic function, learning and thinking. Leads to neural death/degeneration, poor memory and learning, or lack of is related to schizophrenia.

64
Q

Nigro-striatal

A

Dopamine pathway relating to involuntary muscle activity

65
Q

Meso-limbic and meso-cortical

A

Dopamine pathway in which abnormal functioning causes psychotic symptoms

66
Q

Tubero-hypophyseal

A

Dopamine pathway relating to neuroendocrine regulation